![]() |
|||
|
|
|
|
| UPDATE: May 2009 | MW: 82.12 | MF: C4H6N2 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 58,800 mg/kg (14 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 49,000 mg/kg (14 week prior to copulation)
|
Reproductive: Maternal effects: Menstrual cycle changes or disorders
|
ARTODN 80,169,2006
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 480 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
TXAPA9 14,301,1969
|
oral | mouse
lethal dose (50 percent kill): 1,400 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold
|
TXAPA9 14,301,1969
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 54 gm/kg/90 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOXID9 15,202,1995
|
oral | mouse
lowest published toxic dose: 108 gm/kg/90 day- intermittent
|
Endocrine: Evidence of thyroid hyperfunction | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOXID9 30,203,1996
|
oral | mouse
lowest published toxic dose: 14,700 mg/kg/14 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 13,725 mg/kg/26 week- intermittent
|
Liver: Tumors | Blood: Changes in spleen
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 57,645 mg/kg/26 week- intermittent
|
Liver: Tumors | Endocrine: Changes in thyroid weight
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 57,645 mg/kg/26 week- intermittent
|
Kidney, Ureter, and Bladder: Other changes
|
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 27,450 mg/kg/26 week- intermittent
|
Liver: Other changes | Endocrine: Changes in thyroid weight
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 231,525 mg/kg/105 week- intermittent
|
Endocrine: Thyroid tumors | Reproductive: Other reproductive system tumors
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 110,250 mg/kg/105 week- intermittent
|
Endocrine: Other changes | Blood: Changes in bone marrow not included in above
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 59,475 mg/kg/26 week- intermittent
|
Liver: Tumors | Liver: Changes in liver weight Blood: Changes in spleen
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 27,450 mg/kg/26 week- intermittent
|
Liver: Other changes | Liver: Tumors
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 110,250 mg/kg/105 week- intermittent
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
NTPTR* TR-516
|
oral | mouse
lowest published toxic dose: 2,160 mg/kg/15 day- continuous
|
Endocrine: Other changes
|
ARTODN 80,169,2006
|
oral | mouse
lowest published toxic dose: 7,350 mg/kg/14 week- continuous
|
Liver: Changes in liver weight | Cardiac: Changes in heart weight
ARTODN 80,169,2006
|
oral | mouse
lowest published toxic dose: 7,350 mg/kg/14 week- continuous
|
Endocrine: Changes in spleen weight
|
ARTODN 80,169,2006
|
oral | mouse
lowest published toxic dose: 14,700 mg/kg/14 week- continuous
|
Kidney, Ureter, and Bladder: Other changes | Blood: Normocytic anemia Blood: Changes in spleen
ARTODN 80,169,2006
|
oral | mouse
lowest published toxic dose: 14,700 mg/kg/14 week- continuous
|
Endocrine: Changes in spleen weight | Blood: Normocytic anemia
ARTODN 80,169,2006
|
oral | mouse
lowest published toxic dose: 29,400 mg/kg/14 week- continuous
|
Endocrine: Other changes | Blood: Changes in spleen
ARTODN 80,169,2006
|
oral | mouse
lowest published toxic dose: 58,800 mg/kg/14 week- continuous
|
Cardiac: Changes in heart weight | Endocrine: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ARTODN 80,169,2006
|
oral | mouse
lowest published toxic dose: 58,800 mg/kg/14 week- continuous
|
Kidney, Ureter, and Bladder: Other changes | Endocrine: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ARTODN 80,169,2006
|
oral | mouse
lowest published toxic dose: 110.250 gm/kg/105 week- continuous
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
TOPADD 33,313,2005
|
oral | mouse
lowest published toxic dose: 231.525 gm/kg/105 week- continuous
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TOPADD 33,313,2005
|
oral | rat
lowest published toxic dose: 13,500 mg/kg/90 day- continuous
|
Endocrine: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOXID9 15,202,1995
|
oral | rat
lowest published toxic dose: 11,250 mg/kg/90 day- intermittent
|
Endocrine: Evidence of thyroid hyperfunction | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOXID9 30,203,1996
|
oral | rat
lowest published toxic dose: 11,760 mg/kg/14 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 12,740 mg/kg/14 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 22,540 mg/kg/14 week- intermittent
|
Behavioral: Food intake (animal)
|
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 2,379 mg/kg/26 week- intermittent
|
Liver: Other changes | Blood: Microcytosis with or without anemia
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 9,150 mg/kg/26 week- intermittent
|
Liver: Other changes | Endocrine: Other changes Blood: Microcytosis with or without anemia
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 23,790 mg/kg/26 week- intermittent
|
Endocrine: Thyroid tumors | Endocrine: Changes in thyroid weight
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 21,960 mg/kg/26 week- intermittent
|
Endocrine: Changes in thyroid weight
|
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 42,090 mg/kg/26 week- intermittent
|
Endocrine: Thyroid tumors
|
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 7,320 mg/kg/26 week- intermittent
|
Endocrine: Other changes
|
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 29,680 mg/kg/106 week- intermittent
|
Liver: Tumors
|
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 89,040 mg/kg/106 week- intermittent
|
Liver: Change in gall bladder structure or function | Liver: Tumors
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 170,660 mg/kg/106 week- intermittent
|
Blood: Changes in spleen
|
NTPTR* TR-516
|
oral | rat
lowest published toxic dose: 2,970 mg/kg/15 day- continuous
|
Endocrine: Other changes
|
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 9,000 mg/kg/15 day- continuous
|
Behavioral: Food intake (animal) | Endocrine: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 3,675 mg/kg/14 week- continuous
|
Kidney, Ureter, and Bladder: Changes in kidney weight | Related to Chronic Data: Changes in testicular weight
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 14,700 mg/kg/14 week- continuous
|
Endocrine: Evidence of thyroid hypofunction | Endocrine: Other changes
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 29,400 mg/kg/14 week- continuous
|
Behavioral: Food intake (animal) | Endocrine: Evidence of thyroid hypofunction Blood: Normocytic anemia
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 24,500 mg/kg/14 week- continuous
|
Endocrine: Evidence of thyroid hypofunction | Blood: Normocytic anemia
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 58,800 mg/kg/14 week- continuous
|
Endocrine: Thyroid tumors | Endocrine: Evidence of thyroid hypofunction Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 49,000 mg/kg/14 week- continuous
|
Behavioral: Food intake (animal) | Endocrine: Evidence of thyroid hypofunction Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ARTODN 80,169,2006
|
oral | rat
lowest published toxic dose: 29.400 gm/kg/105 week- continuous
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
TOPADD 33,313,2005
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
MUREAV 659,248,2008
|
TOXICOLOGY REVIEW
|
|
MUREAV 659,248,2008
|
TOXICOLOGY REVIEW
|
|
MUREAV 657,84,2008
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: A1324; | Number of Industries 4; Total Number of Facilities 67; Number of Occupations 6; Total Number of Employees Exposed 418
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: A1324 |
Number of Industries 11; Total Number of Facilities 318; Number of Occupations 22; Total Number of Employees Exposed 7,023; Total Number of Female Employees Exposed 3,073 | ||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
NTP Carcinogenesis studies; on test (two year studies), October 2000
|
NTP Carcinogenesis studies; test completed (peer review), October 2000
|
| ||||
REFERENCES:
CODEN
|
|
REFERENCE
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NTPTR*
|
National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709)
No.206-
|
TOPADD
|
Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical
Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
| |